Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (251-260 of 789) with videos related to

Pageof 79
Sort By:
Nature|February 4, 1982
Unusual interactions of benzodiazepine receptor antagonistsD J Nutt, P J Cowen, H J Little
Psychopharmacology|January 1, 1982
Using Ro 15-1788 to investigate the benzodiazepine receptor in vivo: studies on the anticonvulsant and sedative effect of melatonin and the convulsant effect of the benzodiazepine Ro 05-3663A R Green, D J Nutt, P J Cowen
The British Journal of Psychiatry : the Journal of Mental Science|April 1, 1994
Successful treatment of night terrors and somnambulism with paroxetineA R Lillywhite, S J Wilson, D J Nutt
Journal of Psychopharmacology (Oxford, England)|April 11, 2000
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for PsychopharmacologyI M Anderson, D J Nutt, J F Deakin
Acta Psychiatrica Scandinavica|May 1, 2001
Social phobia: illness or illusion?S V Argyropoulos, S D Hood, D J Nutt
European Journal of Pharmacology|January 14, 2003
Naloxone displacement at opioid receptor sites measured in vivo in the human brainJan K Melichar, David J Nutt, Andrea L Malizia
Advances in Biochemical Psychopharmacology|January 1, 1995
Benzodiazepine receptor function in anxiety disordersA L Malizia, N J Coupland, D J Nutt
International Clinical Psychopharmacology|January 1, 1995
Use of selective serotonin reuptake inhibitors and other serotonergic drugs in the biological dissection of affective disordersD J Nutt, S J Wilson, N J Coupland
BMJ (Clinical Research Ed.)|February 3, 2026
Ketamine: reclassification alone will not reduce harmsAdam R Winstock, David J Nutt, Caroline S Copeland
Neuropharmacology|October 1, 1980
On the measurement in rats of the convulsant effect of drugs and the changes which follow electroconvulsive shockD J Nutt, P J Cowen, A R Green
Pageof 79

Showing results (251-260 of 789) with videos related to

Sort By:
Pageof 79
Nature|February 4, 1982
Unusual interactions of benzodiazepine receptor antagonistsD J Nutt, P J Cowen, H J Little
Psychopharmacology|January 1, 1982
Using Ro 15-1788 to investigate the benzodiazepine receptor in vivo: studies on the anticonvulsant and sedative effect of melatonin and the convulsant effect of the benzodiazepine Ro 05-3663A R Green, D J Nutt, P J Cowen
The British Journal of Psychiatry : the Journal of Mental Science|April 1, 1994
Successful treatment of night terrors and somnambulism with paroxetineA R Lillywhite, S J Wilson, D J Nutt
Journal of Psychopharmacology (Oxford, England)|April 11, 2000
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for PsychopharmacologyI M Anderson, D J Nutt, J F Deakin
Acta Psychiatrica Scandinavica|May 1, 2001
Social phobia: illness or illusion?S V Argyropoulos, S D Hood, D J Nutt
European Journal of Pharmacology|January 14, 2003
Naloxone displacement at opioid receptor sites measured in vivo in the human brainJan K Melichar, David J Nutt, Andrea L Malizia
Advances in Biochemical Psychopharmacology|January 1, 1995
Benzodiazepine receptor function in anxiety disordersA L Malizia, N J Coupland, D J Nutt
International Clinical Psychopharmacology|January 1, 1995
Use of selective serotonin reuptake inhibitors and other serotonergic drugs in the biological dissection of affective disordersD J Nutt, S J Wilson, N J Coupland
BMJ (Clinical Research Ed.)|February 3, 2026
Ketamine: reclassification alone will not reduce harmsAdam R Winstock, David J Nutt, Caroline S Copeland
Neuropharmacology|October 1, 1980
On the measurement in rats of the convulsant effect of drugs and the changes which follow electroconvulsive shockD J Nutt, P J Cowen, A R Green
Pageof 79